BR112023016953A2 - Cianobactéria modificada, método de produção decianobactéria modificada, e método de produção de proteínas - Google Patents
Cianobactéria modificada, método de produção decianobactéria modificada, e método de produção de proteínasInfo
- Publication number
- BR112023016953A2 BR112023016953A2 BR112023016953A BR112023016953A BR112023016953A2 BR 112023016953 A2 BR112023016953 A2 BR 112023016953A2 BR 112023016953 A BR112023016953 A BR 112023016953A BR 112023016953 A BR112023016953 A BR 112023016953A BR 112023016953 A2 BR112023016953 A2 BR 112023016953A2
- Authority
- BR
- Brazil
- Prior art keywords
- production method
- modified
- decyanobacteria
- cyanobacteria
- protein production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01098—Rhizobium leguminosarum exopolysaccharide glucosyl ketal-pyruvate-transferase (2.5.1.98)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021034071 | 2021-03-04 | ||
| PCT/JP2022/008657 WO2022186216A1 (ja) | 2021-03-04 | 2022-03-01 | 改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023016953A2 true BR112023016953A2 (pt) | 2023-10-31 |
Family
ID=83154393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023016953A BR112023016953A2 (pt) | 2021-03-04 | 2022-03-01 | Cianobactéria modificada, método de produção decianobactéria modificada, e método de produção de proteínas |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240084245A1 (https=) |
| JP (1) | JPWO2022186216A1 (https=) |
| BR (1) | BR112023016953A2 (https=) |
| MX (1) | MX2023010047A (https=) |
| WO (1) | WO2022186216A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021100640A1 (ja) * | 2019-11-21 | 2021-05-27 | パナソニックIpマネジメント株式会社 | 改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法 |
-
2022
- 2022-03-01 MX MX2023010047A patent/MX2023010047A/es unknown
- 2022-03-01 JP JP2023503872A patent/JPWO2022186216A1/ja active Pending
- 2022-03-01 WO PCT/JP2022/008657 patent/WO2022186216A1/ja not_active Ceased
- 2022-03-01 BR BR112023016953A patent/BR112023016953A2/pt unknown
-
2023
- 2023-08-25 US US18/456,037 patent/US20240084245A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240084245A1 (en) | 2024-03-14 |
| MX2023010047A (es) | 2023-09-05 |
| JPWO2022186216A1 (https=) | 2022-09-09 |
| WO2022186216A1 (ja) | 2022-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022021445A2 (pt) | Métodos e composições para tratar condições inflamatórias associadas com doença infecciosa | |
| BR112019009106A2 (pt) | método para aumentar os níveis de secreção sem afetar as funções biológicas de il-2 de humano recombinante e suas proteínas mutantes derivadas, proteínas obtidas, e, usos do método e das proteínas obtidas | |
| BR112022027096A2 (pt) | Composições e métodos relacionados a agentes terapêuticos ativáveis | |
| BR112022022524A2 (pt) | Proteínas imunomoduladoras inibidoras de april e baff com e sem uma proteína inibidora de células t e métodos de uso das mesmas | |
| BR112022009890A2 (pt) | Micela recombinante e método de montagem in vivo | |
| BR112015019066A2 (pt) | Anticorpos humanos para proteína f do vírus respiratório sincicial e métodos de uso dos mesmos | |
| BR112016004375A2 (pt) | método de produção de acilaminoácidos | |
| BR112013019258A8 (pt) | Uso de uma formulação probiótica compreendendo uma cepa de bifidobacterium bifidum | |
| BR112022016495A2 (pt) | Arquitetura dividida para chamador de base baseado em inteligência artificial | |
| BR112022000394A2 (pt) | Produção de fucosilactose em células hospedeiras | |
| BRPI0801858A2 (pt) | uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica | |
| BRPI0808522A8 (pt) | Uso de lactobacillus plantarum para aumentar diversidade bacterial | |
| BRPI0517514A (pt) | vesìculas bacterianas imunogênicas com proteìnas da membrana externa | |
| CL2021000446A1 (es) | Métodos para la normalización del metabolismo de aminoácidos | |
| BR112023004871A2 (pt) | Métodos para reduzir o conteúdo de proteínas das células hospedeiras em processos de purificação de proteínas | |
| BR112014016815A8 (pt) | conjunto de ventilação de fabricação de compósito e modo de conexão | |
| JP2016505254A (ja) | 下痢を治療および/または予防するプロバイオティクス株 | |
| BR112023016953A2 (pt) | Cianobactéria modificada, método de produção decianobactéria modificada, e método de produção de proteínas | |
| BR112023020341A2 (pt) | Anticorpo multiespecífico, composição farmacêutica, método para tratar uma doença relacionada à expressão de bcma e anticorpo de ligação a bcma | |
| BR112022006923A2 (pt) | Polipeptídeos recombinantes para localização celular regulável | |
| BR112023003526A2 (pt) | Proteínas de fusão de coronavírus imunogênicos e métodos relacionados | |
| CO2025000674A2 (es) | Anticuerpos que se unen a la pad4 humana y usos de los mismos | |
| BR112021022900A2 (pt) | Expressão de proteínas modificadas em peroxissoma | |
| BR112018077225A2 (pt) | proteínas de fusão tatk-cdkl5, composições, formulações e uso das mesmas | |
| BR112016008086A2 (pt) | Glicoproteínas recombinantes e usos das mesmas |